SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $47,155,240 |
| Positions | 9 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD | WVE | SHS | $26,657,930 | 4,588,284 |
| INVIVYD INC | IVVD | COM | $8,068,173 | 9,248,250 |
| TG THERAPEUTICS INC | TGTX | COM | $4,854,169 | 88,354 |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | COM | $3,003,725 | 36,851 |
| FRACTYL HEALTH INC | GUTS | COM | $1,474,499 | 1,856,117 |
| PROQR THRAPEUTICS N V | PRQR | SHS EURO | $1,115,615 | 599,793 |
| SILENCE THERAPEUTICS PLC | SLN | ADS | $1,111,209 | 101,203 |
| ROCKET PHARMACEUTICALS INC | RCKT | COM | $721,179 | 210,871 |
| CURIS INC | CRIS | COM | $148,741 | 284,889 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.